Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Curb Q4 Earnings Beats Estimates By 0.01 20260403 Cste Declines As Market Sentiment Shifts 20260401 1 Pbr Stock Analysis Petroleo Brasileiro Petrobras Ads 2.39 Gain At 20.56 Level 20260403 Is SharkNinja SN stock in a strong position Q4 2025 EPS Exceeds Expectations Energys ENGS Stock Trade Confirmation Builds on Momentum 20260415 ONEOK Inc OKE Reports Q1 2026 Earnings Revenue Growth Solid Mixed Performance Across Business Segments GEN GENK Stock Risk Q4 2025 EPS Exceeds Expectations XPEL XPEL Stock Research XPEL Inc posts 74 EPS beat on strong auto sales GHG GreenTree Hospitality Group Ltd posts 36 percent Q3 2024 EPS beat with shares climbing modestly following the earnings release Why Veracyte VCYT earnings could be a turning point Q1 2026 EPS Beats Forecasts BBUC Brookfld Biz CEO outlines crosssector investment plans to boost longterm organic growth momentum Why Agios AGIO financial health is stronger than most think In Focus 20260508 ZH Zhihu Inc posts steep Q4 2025 EPS miss shares record zero daily price change OPTXW Syntec investors seek quarterly earnings clarity to assess its core custom optics segment expansion plans The valuation case for OFS Credit OCCIN that is hard to ignore Motionless 20260505 ServiceNow Inc NOW Robust Partner Ecosystem Drives LongTerm AI Upside Amid NearTerm Valuation and Competitive Headwinds Amazoncom Inc AMZN Emerges As Core Growth Channel Following Este Lauders Blowout Q3 Earnings Beat First Trust Natural Gas ETF FCG 2026 Investment Viability Analysis and Peer Benchmarking Redwood Trust RWT Jumps 135 on Strong Momentum 20260518 Kelly Services KELYA Q1 2026 Results Fall Short EPS 003 Revenue NA Jim Cramer on Navigating Market Rotation Buy the Pullbacks Not the Rallies C4 Thera CCCC Fell 955 Is a Recovery Ahead 20260518 Southern SO Surges 142 Nearing 9774 Resistance 20260518 Marvell Stock Pops on Positive Wall Street Sentiment Protagonist Therapeutics PTGX Declines 319 Amid Market Weakness 20260517